Nicholas Boyd

Company: Cartherics

Job title: Chief Development Officer

Seminars:

Advancing Off-The-Shelf Immunotherapy for Solid Tumors: Using Gene-Edited iNK Cells 3:30 pm

What are the important features for product-centric, ‘off-the-shelf’ immunotherapy, and how can we create this? Establishing gene-editing and manufacture systems for functionally enhanced iPSC derived iNK cells Translating allogeneic products to the clinic: the development of CTH-401Read more

day: Day Two